BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7154620)

  • 1. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
    Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
    Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
    Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
    Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three immunoassays for immune complexes in rheumatoid arthritis.
    Gupta RC; McDuffie FC; Huston KA; Tappeiner G; Meurer M; Jordon RE; Luthra HS; Hunder GG; Ilstrup D
    Arthritis Rheum; 1979 May; 22(5):433-9. PubMed ID: 87203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
    Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
    Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
    Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
    Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in patients with rheumatoid arthritis: correlation with disease activity.
    Levo Y; Fischel R; Ehrenfeld M
    J Rheumatol; 1981; 8(5):851-5. PubMed ID: 7310781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
    Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
    J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of circulating immune complexes in patients with breast cancer.
    Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
    Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
    Ronai Z; Shaham J; Stein J; Sulitzeanu D
    Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
    Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
    J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and rheumatoid arthritis: a comparison of different assay methods and their early predictive value for disease activity and outcome.
    Reeback JS; Silman AJ; Holborow EJ; Maini RN; Hay FC
    Ann Rheum Dis; 1985 Feb; 44(2):79-82. PubMed ID: 3872100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
    Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
    Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes.
    Herrmann D; Jäger L; Hein G; Henzgen M; Schlenvoigt G
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):302-7. PubMed ID: 1669588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on circulating immune complexes. I: Circulating immune complexes in various types of glomerulonephritis and collagen disease: a comparative study employing conglutinin solid phase radioimmunoassay and raji cell radioimmunoassay.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):185-92. PubMed ID: 2739117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of circulating immune complexes in patients with ankylosing spondylitis.
    Maksymowych W; Dasgupta MK; Rothwell RS; Dossetor JB; Russell AS
    Rheumatol Int; 1981; 1(3):107-9. PubMed ID: 6981182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.
    Manzo C; Longo C; Bianchin A
    Tumori; 1982 Feb; 68(1):47-52. PubMed ID: 7041380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of circulating immune complexes in cancer patients.
    Dass TK; Aziz M; Rattan A
    Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.